Southeast Asia nutritional supplements market will grow by 9.9% annually to approach $26.87 billion by 2032, driven by the increasing health consciousness amid COVID-19 pandemic, improved purchasing power, availability of novel nutrition products, and growing consumer preferences for healthier dietary options.
Highlighted with 58 tables and 90 figures, this 173-page report "Southeast Asia Nutritional Supplements Market 2022-2032 by Ingredient, Product Form, Category, Application, End User, Supplement Classification, Distribution Channel, and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Southeast Asia nutritional supplements market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Southeast Asia market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Southeast Asia nutritional supplements market in every aspect of the classification from perspectives of Ingredient, Product Form, Category, Application, End User, Supplement Classification, Distribution Channel, and Region.
Based on Ingredient, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Botanicals
• Vitamins
o Vitamin A
o Vitamin B
o Vitamin C
o Vitamin D
o Vitamin E
o Vitamin K
o Multivitamins
• Minerals
o Iron Supplements
o Calcium Supplements
o Magnesium & Zinc Supplements
o Multi-Mineral Supplements
o Other Minerals
• Proteins & Amino Acids
• Fish Oils
• Fibers & Specialty Carbohydrates
• Enzymes
• Probiotic Supplements
• Other Ingredients
Based on Product Form, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Tablets
• Capsules
• Powder
• Liquids
• Soft Gels & Gel Caps
• Gummies
• Other Product Forms
By Category, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Additional Supplements
• Medicinal Supplements
• Sports Nutrition
By Application, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Other Applications
By End User, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infant
• Children
• Adults
• Pregnant Women
• Elderly People
By Supplement Classification, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• OTC Supplements
• Prescription Supplements
By Distribution Channel, the Southeast Asia market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Retail Stores & Hospitals
• Supermarkets & Hypermarkets
• Online Stores
• Direct Selling
• Other Distribution Channels
Geographically, the following national/local markets are fully investigated:
• Hong Kong
• Taiwan
• Indonesia
• Malaysia
• Vietnam
• Thailand
• Singapore
• Philippines
• Rest of Southeast Asia
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Ingredient, Product Form, Category, End User, and Distribution Channel over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ADM
American Health
Amway Corporation
Archer Daniels Midland Company
Arkopharma Laboratoires Pharmaceutiques
Ayanda
Bayer
Bionova Lifesciences
Carlyle Group
DuPont
DSM
Ekomir
Glanbia Nutritionals
GlaxoSmithKline
Herbalife International
Himalaya Southeast Asia Holdings Ltd.
Nature's Sunshine Products
Nestle Nutritionals
NBTY, Inc.
Pfizer Inc.
Stepan
XanGo
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Thailand-Ukraine Conflict: War Slows Economic Recovery 29
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 44
3 Segmentation of Southeast Asia Market by Ingredient 48
3.1 Market Overview by Ingredient 48
3.2 Botanicals 50
3.3 Vitamins 51
3.3.1 Vitamin A 53
3.3.2 Vitamin B 54
3.3.3 Vitamin C 55
3.3.4 Vitamin D 56
3.3.5 Vitamin E 57
3.3.6 Vitamin K 58
3.3.7 Multivitamins 59
3.4 Minerals 60
3.4.1 Iron Supplements 62
3.4.2 Calcium Supplements 63
3.4.3 Magnesium & Zinc Supplements 64
3.4.4 Multi-Mineral Supplements 65
3.4.5 Other Minerals 66
3.5 Proteins & Amino Acids 67
3.6 Fish Oils 68
3.7 Fibers & Specialty Carbohydrates 69
3.8 Enzymes 70
3.9 Probiotic Supplements 71
3.10 Other Ingredients 72
4 Segmentation of Southeast Asia Market by Product Form 73
4.1 Market Overview by Product Form 73
4.2 Tablets 75
4.3 Capsules 76
4.4 Powder 77
4.5 Liquids 78
4.6 Soft Gels & Gel Caps 79
4.7 Gummies 80
4.8 Other Product Forms 81
5 Segmentation of Southeast Asia Market by Category 82
5.1 Market Overview by Category 82
5.2 Additional Supplements 84
5.3 Medicinal Supplements 85
5.4 Sports Nutrition 86
6 Segmentation of Southeast Asia Market by Application 87
6.1 Market Overview by Application 87
6.2 Energy & Weight Management 89
6.3 General Health 90
6.4 Bone & Joint Health 91
6.5 Gastrointestinal Health 92
6.6 Immunity 93
6.7 Cardiac Health 94
6.8 Diabetes 95
6.9 Anti-cancer 96
6.10 Other Applications 97
7 Segmentation of Southeast Asia Market by End User 98
7.1 Market Overview by End User 98
7.2 Infant 100
7.3 Children 101
7.4 Adults 102
7.5 Pregnant Women 103
7.6 Elderly People 104
8 Segmentation of Southeast Asia Market by Supplement Classification 105
8.1 Market Overview by Supplement Classification 105
8.2 OTC Supplements 107
8.3 Prescription Supplements 108
9 Segmentation of Southeast Asia Market by Distribution Channel 109
9.1 Market Overview by Distribution Channel 109
9.2 Retail Stores & Hospitals 111
9.3 Supermarkets & Hypermarkets 112
9.4 Online Stores 113
9.5 Direct Selling 114
9.6 Other Distribution Channels 115
10 Southeast Asia Market 2022-2032 by Region 116
10.1 Overview of Southeast Asia Market 116
10.2 Hong Kong 120
10.3 Taiwan 123
10.4 Indonesia 126
10.5 Malaysia 129
10.6 Vietnam 132
10.7 Thailand 135
10.8 Singapore 138
10.9 Philippines 141
10.10 Rest of Southeast Asia Market 144
11 Competitive Landscape 145
11.1 Overview of Key Vendors 145
11.2 New Product Launch, Partnership, Investment, and M&A 148
11.3 Company Profiles 149
Abbott Laboratories 149
ADM 151
American Health 152
Amway Corporation 153
Archer Daniels Midland Company 154
Arkopharma Laboratoires Pharmaceutiques 155
Ayanda 156
Bayer 157
Bionova Lifesciences 158
Carlyle Group 159
DuPont 160
DSM 161
Ekomir 162
Glanbia Nutritionals 163
GlaxoSmithKline 164
Herbalife International 165
Himalaya Southeast Asia Holdings Ltd. 166
Nature's Sunshine Products 167
Nestle Nutritionals 168
NBTY, Inc. 169
Pfizer Inc. 170
Stepan 171
XanGo 172
RELATED REPORTS 173
The Specialized Clinical Nutritional Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
Asia Pacific cutting tools market will grow by 6.0% annually with a total addressable market cap of $163.03 billion over 2024-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for powe...
Asia Pacific paper machine clothing (PMC) market will grow by 5.3% annually with a total addressable market cap of $7.27 billion over 2024-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking p...
Asia Pacific endoscopy devices market will grow by 7.7% annually with a total addressable market cap of $150.27 billion over 2024-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic c...
Asia Pacific digital health and wellness market will grow by 20.8% annually with a total addressable market cap of $3,072.0 billion over 2024-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphon...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Asia Pacific encoder market will grow by 10.6% annually with a total addressable market cap of $18.21 billion over 2024-2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological ...
Asia Pacific specialty coffee market will grow by 14.7% annually with a total addressable market cap of $266.39 billion over 2024-2033. The growth is driven by rising disposable income and urbanization, growing demand for on-the-go coffee, strengthening premium coffee shops, and rising preferences f...